Annual EBIT
-$197.73 M
+$61.55 M+23.74%
December 31, 2023
Summary
- As of February 7, 2025, CHRS annual earnings before interest & taxes is -$197.73 million, with the most recent change of +$61.55 million (+23.74%) on December 31, 2023.
- During the last 3 years, CHRS annual EBIT has fallen by -$354.60 million (-226.04%).
- CHRS annual EBIT is now -226.04% below its all-time high of $156.87 million, reached on December 31, 2020.
Performance
CHRS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.39 M
+$2.20 M+28.97%
September 30, 2024
Summary
- As of February 7, 2025, CHRS quarterly earnings before interest & taxes is -$5.39 million, with the most recent change of +$2.20 million (+28.97%) on September 30, 2024.
- Over the past year, CHRS quarterly EBIT has increased by +$24.36 million (+81.89%).
- CHRS quarterly EBIT is now -104.73% below its all-time high of $113.99 million, reached on March 31, 2024.
Performance
CHRS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$31.98 M
+$24.36 M+319.86%
September 30, 2024
Summary
- As of February 7, 2025, CHRS TTM earnings before interest & taxes is $31.98 million, with the most recent change of +$24.36 million (+319.86%) on September 30, 2024.
- Over the past year, CHRS TTM EBIT has increased by +$210.16 million (+117.95%).
- CHRS TTM EBIT is now -84.38% below its all-time high of $204.78 million, reached on June 30, 2020.
Performance
CHRS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CHRS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.7% | +81.9% | +118.0% |
| 3 y3 years | -226.0% | +83.6% | +114.1% |
| 5 y5 years | +1.0% | +83.6% | +114.1% |
CHRS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.1% | -104.7% | +93.8% | at high | +112.1% |
| 5 y | 5-year | -226.0% | +25.1% | -104.7% | +96.8% | -84.4% | +112.1% |
| alltime | all time | -226.0% | +25.1% | -104.7% | +96.8% | -84.4% | +112.1% |
Coherus BioSciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.39 M(-29.0%) | $31.98 M(+319.9%) |
| Jun 2024 | - | -$7.59 M(-106.7%) | $7.62 M(-143.0%) |
| Mar 2024 | - | $113.99 M(-265.1%) | -$17.72 M(-91.0%) |
| Dec 2023 | -$197.73 M(-23.7%) | -$69.03 M(+132.0%) | -$197.73 M(+11.0%) |
| Sep 2023 | - | -$29.75 M(-9.6%) | -$178.18 M(-21.7%) |
| Jun 2023 | - | -$32.93 M(-50.1%) | -$227.54 M(-4.5%) |
| Mar 2023 | - | -$66.02 M(+33.4%) | -$238.18 M(-8.1%) |
| Dec 2022 | -$259.28 M(-1.8%) | -$49.48 M(-37.4%) | -$259.28 M(+3.8%) |
| Sep 2022 | - | -$79.11 M(+81.6%) | -$249.73 M(+22.8%) |
| Jun 2022 | - | -$43.57 M(-50.0%) | -$203.37 M(+10.6%) |
| Mar 2022 | - | -$87.11 M(+118.2%) | -$183.96 M(-30.4%) |
| Dec 2021 | -$264.14 M(-268.4%) | -$39.93 M(+21.9%) | -$264.14 M(+27.1%) |
| Sep 2021 | - | -$32.76 M(+35.6%) | -$207.78 M(+47.1%) |
| Jun 2021 | - | -$24.15 M(-85.6%) | -$141.25 M(+175.0%) |
| Mar 2021 | - | -$167.30 M(-1118.2%) | -$51.36 M(-132.7%) |
| Dec 2020 | $156.87 M(+42.1%) | $16.43 M(-51.3%) | $156.87 M(-15.7%) |
| Sep 2020 | - | $33.77 M(-48.6%) | $186.19 M(-9.1%) |
| Jun 2020 | - | $65.73 M(+60.6%) | $204.78 M(+22.6%) |
| Mar 2020 | - | $40.94 M(-10.5%) | $167.10 M(+51.4%) |
| Dec 2019 | $110.38 M(-155.3%) | $45.75 M(-12.6%) | $110.38 M(+2374.8%) |
| Sep 2019 | - | $52.36 M(+86.7%) | $4.46 M(-104.3%) |
| Jun 2019 | - | $28.05 M(-277.7%) | -$104.30 M(-39.9%) |
| Mar 2019 | - | -$15.79 M(-73.8%) | -$173.62 M(-13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$199.72 M(-12.7%) | -$60.16 M(+6.7%) | -$199.72 M(+7.2%) |
| Sep 2018 | - | -$56.40 M(+36.7%) | -$186.23 M(-0.1%) |
| Jun 2018 | - | -$41.27 M(-1.5%) | -$186.43 M(-5.9%) |
| Mar 2018 | - | -$41.89 M(-10.2%) | -$198.18 M(-13.4%) |
| Dec 2017 | -$228.73 M(+90.9%) | -$46.67 M(-17.5%) | -$228.73 M(-10.5%) |
| Sep 2017 | - | -$56.60 M(+6.8%) | -$255.64 M(+126.7%) |
| Jun 2017 | - | -$53.02 M(-26.8%) | -$112.78 M(-11.6%) |
| Mar 2017 | - | -$72.45 M(-1.5%) | -$127.55 M(+6.5%) |
| Dec 2016 | -$119.81 M(-46.5%) | -$73.58 M(-185.3%) | -$119.81 M(+21.2%) |
| Sep 2016 | - | $86.26 M(-227.2%) | -$98.81 M(-61.5%) |
| Jun 2016 | - | -$67.80 M(+4.8%) | -$256.53 M(+3.5%) |
| Mar 2016 | - | -$64.70 M(+23.1%) | -$247.77 M(+10.7%) |
| Dec 2015 | -$223.91 M(+168.9%) | -$52.58 M(-26.4%) | -$223.91 M(+11.8%) |
| Sep 2015 | - | -$71.45 M(+21.0%) | -$200.35 M(+46.4%) |
| Jun 2015 | - | -$59.03 M(+44.6%) | -$136.81 M(+34.5%) |
| Mar 2015 | - | -$40.84 M(+40.7%) | -$101.69 M(+22.1%) |
| Dec 2014 | -$83.28 M(+72.3%) | -$29.02 M(+266.8%) | -$83.28 M(+27.1%) |
| Sep 2014 | - | -$7.91 M(-66.9%) | -$65.54 M(-15.0%) |
| Jun 2014 | - | -$23.91 M(+6.6%) | -$77.11 M(+44.9%) |
| Mar 2014 | - | -$22.43 M(+98.7%) | -$53.20 M(+72.9%) |
| Dec 2013 | -$48.34 M(+53.4%) | -$11.29 M(-42.0%) | -$30.77 M(+58.0%) |
| Sep 2013 | - | -$19.48 M | -$19.48 M |
| Dec 2012 | -$31.50 M | - | - |
FAQ
- What is Coherus BioSciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Coherus BioSciences?
- What is Coherus BioSciences annual EBIT year-on-year change?
- What is Coherus BioSciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Coherus BioSciences?
- What is Coherus BioSciences quarterly EBIT year-on-year change?
- What is Coherus BioSciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Coherus BioSciences?
- What is Coherus BioSciences TTM EBIT year-on-year change?
What is Coherus BioSciences annual earnings before interest & taxes?
The current annual EBIT of CHRS is -$197.73 M
What is the all time high annual EBIT for Coherus BioSciences?
Coherus BioSciences all-time high annual earnings before interest & taxes is $156.87 M
What is Coherus BioSciences annual EBIT year-on-year change?
Over the past year, CHRS annual earnings before interest & taxes has changed by +$61.55 M (+23.74%)
What is Coherus BioSciences quarterly earnings before interest & taxes?
The current quarterly EBIT of CHRS is -$5.39 M
What is the all time high quarterly EBIT for Coherus BioSciences?
Coherus BioSciences all-time high quarterly earnings before interest & taxes is $113.99 M
What is Coherus BioSciences quarterly EBIT year-on-year change?
Over the past year, CHRS quarterly earnings before interest & taxes has changed by +$24.36 M (+81.89%)
What is Coherus BioSciences TTM earnings before interest & taxes?
The current TTM EBIT of CHRS is $31.98 M
What is the all time high TTM EBIT for Coherus BioSciences?
Coherus BioSciences all-time high TTM earnings before interest & taxes is $204.78 M
What is Coherus BioSciences TTM EBIT year-on-year change?
Over the past year, CHRS TTM earnings before interest & taxes has changed by +$210.16 M (+117.95%)